Crossmark

Precision targeting of the SASP in cancer therapy

Crossref DOI link: https://doi.org/10.1038/s43587-025-01052-4

Published Online: 2026-02-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hassan, Saima

Ferbeyre, Gerardo https://orcid.org/0000-0002-2146-618X
License Information

Text and Data Mining valid from 2026-02-03

Version of Record valid from 2026-02-03
More Information

Article History

First Online: 3 February 2026

Competing interests

: S.H. received speaker bureau fees from AstraZeneca-Merck and research funding from Exact Sciences and Pfizer. G.F. declares no competing interests.